0

Global Esophageal Cancer Drugs Market 2019-2023

  • Published: Mar 2019
  • Pages: 118
  • SKU: IRTNTR30982
Technavio

The 2022-2026 version of this report is just being published. Buy it now and get up to $1000 worth of free customization!

Get me the latest version! (includes COVID-19 impact)
Safe and Secure SSL Encrypted
  • 2500.00
  • USD

The global esophageal cancer drugs market size will grow by USD 1.5 billion during 2019-2023. This report offers an analysis of the market based on product (targeted therapy and chemotherapy) and type (adenocarcinoma and squamous cell carcinoma). The esophageal cancer drugs market research report further presents in-depth insights on the growth prospects of the market across geographic regions such as Asia, Europe, North America, and ROW. The report analyzes the market’s competitive landscape and offers information on several companies including Bristol-Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche Ltd, Merck & Co., Inc., and Sanofi.

Below are some of the key findings from the esophageal cancer drugs market analysis report

Esophageal Cancer Drugs Market

See the complete table of contents and list of exhibits, as well as selected illustrations and example pages from this report.

Get a FREE sample now!

Global Esophageal Cancer Drugs Industry Overview

Various combinations of drugs such as fluorouracil, cisplatin, docetaxel, and carboplatin are involved in standard chemotherapy regimens for the treatment of esophageal cancer. These drugs are selected based on adverse drug reactions and cancer subtypes. To ensure patient access to available therapeutics, governments in developed countries are introducing reimbursement policies. Medicare comprising of Medicare Part A (hospital insurance) and Medicare Part B (medical insurance) is a federal government program for healthcare in the US that covers chemotherapy for cancer patients. Similarly, the Ministry of Health and Long-term Care in Canada provides funds for CYRAMZA and Health Insurance Review and Assessment Service of South Korea has approved CYRAMZA for the treatment of esophageal cancer. The availability of such favorable reimbursements is one of the critical reasons that will drive esophageal cancer drugs market growth.

Additionally, the use of multimodality treatment approach will also contribute to the growth of the esophageal cancer drugs market which will register a CAGR of over 8% during the forecast period. The optimal treatment of esophageal cancer requires a combination of chemotherapy. This treatment approach aims at providing optimal treatment for esophageal cancer by combining the strengths of various treatments such as chemotherapy and targeted therapy (immunotherapy). It also combines procedures such as perioperative chemotherapy or definitive chemoradiation, radiotherapy, and surgery, which will help improve patient outcome and enhance the survival rate.

Top esophageal cancer drugs companies covered in this market research report

The esophageal cancer drugs market is fairly fragmented. By offering a complete analysis of the market’s competitive landscape and with information on the products offered by companies, this esophageal cancer drugs industry analysis report will help clients identify new growth opportunities and design innovative strategies to improve their share in the market.

The report offers a complete analysis of various companies including:

  • Bristol-Myers Squibb Company
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd
  • Merck & Co., Inc.
  • Sanofi

Esophageal cancer drugs market segmentation based on geographic regions

  • Asia
  • Europe
  • North America
  • ROW

North America will account for the largest esophageal cancer drugs market share throughout the forecast period. The growth of esophageal cancer drugs market size in this region is due to major factors such as increasing incidence of esophageal cancer, availability of favorable reimbursement schemes, government initiatives, and growing awareness of esophageal cancer.

Esophageal cancer drugs market segmentation based on product

  • Targeted therapy
  • Chemotherapy

The targeted therapy market segment will account for the highest esophageal cancer drugs market share because of the increasing research on novel drugs. This involves targeting specific proteins such as the vascular endothelial growth factor (VEGF) or human epidermal growth factor receptor 2 (HER2) that contribute to cancer growth and survival.

Key highlights of the global esophageal cancer drugs market for the forecast years 2019-2023:

  • CAGR of the market during the forecast period 2019-2023
  • Detailed information on factors that will accelerate the growth of the esophageal cancer drugs market during the next five years
  • Precise estimation of the global esophageal cancer drugs market size and its contribution to the parent market
  • Accurate predictions on upcoming trends and changes in consumer behavior
  • The growth of the esophageal cancer drugs industry across various geographies such as Asia, Europe, North America, and ROW
  • A thorough analysis of the market’s competitive landscape and detailed information on several vendors
  • Comprehensive details on factors that will challenge the growth of esophageal cancer drugs companies 

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch

 

Read More Read Less

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

  • 2.1 Preface
  • 2.2 Preface
  • 2.3 Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 04: PIPELINE ANALYSIS

PART 05: MARKET SIZING

  • Market definition
  • Market sizing 2018
  • Market size and forecast 2018-2023

PART 06: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 07: MARKET SEGMENTATION BY PRODUCT

  • Market segmentation by product
  • Comparison by product
  • Targeted therapy - Market size and forecast 2018-2023
  • Chemotherapy - Market size and forecast 2018-2023
  • Market opportunity by product

PART 08: CUSTOMER LANDSCAPE

PART 09: MARKET SEGMENTATION BY TYPE

  • Adenocarcinoma
  • Squamous cell carcinoma

PART 10: GEOGRAPHIC LANDSCAPE

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2018-2023
  • Europe - Market size and forecast 2018-2023
  • Asia - Market size and forecast 2018-2023
  • ROW - Market size and forecast 2018-2023
  • Key leading countries
  • Market opportunity

PART 11: DECISION FRAMEWORK

PART 12: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 13: MARKET TRENDS

PART 14: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption

PART 15: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Bristol-Myers Squibb Company
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd
  • Merck & Co., Inc.
  • Sanofi

PART 16: APPENDIX

  • Research methodology
  • List of abbreviations

PART 17: EXPLORE TECHNAVIO


Research Framework

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

TechnavioINFORMATION SOURCES

Primary sources

  • Manufacturers and suppliers
  • Channel partners
  • Industry experts
  • Strategic decision makers

Secondary sources

  • Industry journals and periodicals
  • Government data
  • Financial reports of key industry players
  • Historical data
  • Press releases
Technavio

TechnavioDATA ANALYSIS

Data Synthesis

  • Collation of data
  • Estimation of key figures
  • Analysis of derived insights

Data Validation

  • Triangulation with data models
  • Reference against proprietary databases
  • Corroboration with industry experts
Technavio

TechnavioREPORT WRITING

Qualitative

  • Market drivers
  • Market challenges
  • Market trends
  • Five forces analysis

Quantitative

  • Market size and forecast
  • Market segmentation
  • Geographical insights
  • Competitive landscape
Interested in this report?
Get your FREE sample now!
Safe and Secure SSL Encrypted
Technavio

Single User:

2500 USD

Technavio Get the report (PDF) sent to your email within minutes.

Subscribe & Save

Get lifetime access to our
Technavio Insights

Want to customize this report?

This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.

We offer $1000 worth of FREE customization at the time of purchase
Technavio
Enquire Before Buying
  1. Home
  2. Health Care
  3. Published Reports 2019
17,000 reports available | Plans starting from just 5,000 USD | Get FREE trial>>